These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15254345)

  • 1. Pharmacological prevention of post-ERCP pancreatitis: the facts and the fiction.
    Testoni PA
    JOP; 2004 Jul; 5(4):171-8. PubMed ID: 15254345
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological prevention of post-ERCP pancreatitis--an everlasting dream?
    Hellmig S; Fölsch UR
    Dig Liver Dis; 2006 Aug; 38(8):596-8. PubMed ID: 16731061
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
    Cooper ST; Slivka A
    Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproteasic agents in the prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Cavallini G; Frulloni L
    JOP; 2003 Jan; 4(1):75-82. PubMed ID: 12555019
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of pancreatic stents in prevention of post-ERCP pancreatitis.
    Freeman ML
    JOP; 2004 Sep; 5(5):322-7. PubMed ID: 15365198
    [No Abstract]   [Full Text] [Related]  

  • 6. The Prevention, recognition and treatment of post-ERCP pancreatitis.
    Badalov N; Tenner S; Baillie J
    JOP; 2009 Mar; 10(2):88-97. PubMed ID: 19287099
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological prevention of post-ERCP pancreatitis: which therapy is best?
    Mariani A
    JOP; 2003 Jan; 4(1):68-74. PubMed ID: 12555018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for the prevention of post-ERCP pancreatitis.
    Foster E; Leung J
    Am J Gastroenterol; 2007 Jan; 102(1):52-5. PubMed ID: 17266688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and prevention of post-ERCP pancreatitis.
    Tittobello A
    Endoscopy; 1997 May; 29(4):285-7. PubMed ID: 9255534
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
    Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic stents for prevention of post-ERCP pancreatitis: for everyday practice or for experts only?
    Freeman ML
    Gastrointest Endosc; 2010 May; 71(6):940-4. PubMed ID: 20438883
    [No Abstract]   [Full Text] [Related]  

  • 12. Post-ERCP pancreatitis and its prevention.
    Frank CD; Adler DG
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):680-8. PubMed ID: 17130878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.
    Wagh MS; Sherman S
    Am J Gastroenterol; 2007 May; 102(5):984-6. PubMed ID: 17489783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endoscopic retrograde cholangiopancreatography: is it possible to effectively prevent ERCP-induced pancreatitis?].
    Il'chenko AA
    Eksp Klin Gastroenterol; 2008; (3):62-71. PubMed ID: 19145885
    [No Abstract]   [Full Text] [Related]  

  • 15. Making sense of meta-analyses on the use of protease inhibitors for the prevention of post-ERCP pancreatitis.
    Baron TH; Itoi T
    Gastrointest Endosc; 2011 Apr; 73(4):707-9. PubMed ID: 21457815
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
    Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
    BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide in the prevention of post-ERCP pancreatic injury.
    Herszenyi L; Tulassay Z
    Am J Gastroenterol; 2007 Jul; 102(7):1539-40. PubMed ID: 17593164
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the rate of post-ERCP pancreatitis not reduced by guide-wire cannulation?
    Park DH; Lee SS; Seo DW; Lee SK; Kim MH
    Endoscopy; 2008 Sep; 40(9):784; author reply 785. PubMed ID: 18773344
    [No Abstract]   [Full Text] [Related]  

  • 20. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.